Immucell (ICCC) Net Equity Issued and Repurchased (2010 - 2025)
Immucell's Net Equity Issued and Repurchased was $349,326 in FY2025, down 92.5% from $4.65 million in FY2024.
Powered by 
Analysis
Immucell (ICCC) Net Equity Issued and Repurchased (2010 - 2025) Analysis & Trends
From FY2009 onward, Immucell has reported Net Equity Issued and Repurchased for 17 years.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 54.7% (FY2020 to FY2025).
- Annual Net Equity Issued and Repurchased has moved between $18,760 (FY2023) and $4.65 million (FY2024) over five years.
- Per Business Quant data, Net Equity Issued and Repurchased in earlier years was $4.65 million in FY2024, $18,760 in FY2023 (-38.8%), $30,670 in FY2022 (-99.3%) and $4.23 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 138.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Immucell | 95.91 Mn | 73.35 Mn | 2.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 329,895.00 |
| Mar 31, 2025 | 19,434.00 |
| Dec 31, 2024 | 539,292.00 |
| Sep 30, 2024 | 3.69 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | -2.00 |
| Jun 30, 2022 | 24,832.00 |
| Mar 31, 2022 | 5,840.00 |
| Sep 30, 2021 | 165,337.00 |
| Jun 30, 2021 | 4.23 Mn |
| Mar 31, 2021 | 11,680.00 |
| Dec 31, 2020 | -32,623.00 |
| Dec 31, 2019 | 1.00 |
| Mar 31, 2019 | 8.30 Mn |
| Dec 31, 2018 | 80,754.00 |
| Sep 30, 2018 | 4,640.00 |
| Jun 30, 2018 | 6,704.00 |
| Mar 31, 2018 | 4,156.00 |
| Dec 31, 2017 | 2.76 Mn |
| Sep 30, 2017 | 1.05 Mn |
API Access
Immucell Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();